Legal Disclaimer
This page provides general legal orientation for Germany, not legal advice. Regulations change frequently. Always verify current rules with BfArM and consult a qualified professional.
Peptide Legal Status in Germany
Germany regulates pharmaceuticals through BfArM and the Paul-Ehrlich-Institut under the German Medicines Act (Arzneimittelgesetz — AMG). GLP-1 agonists are EMA-authorized and available by prescription (verschreibungspflichtig). Germany has a strong pharmacy-based compounding tradition (Apothekenbetriebsordnung). Digital health laws (Digitale-Versorgung-Gesetz) enable telehealth prescribing.
Regulator
BfArM (Federal Institute for Drugs and Medical Devices) — Official website
Key Facts
Compounding Pharmacy Rules
Telehealth Prescribing
Peptide Categories in Germany
Approved
Semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), liraglutide (Saxenda, Victoza) — EMA-authorized and available by prescription. GKV (public insurance) coverage for weight loss medications is limited; many patients pay privately.
Research / Unapproved
BPC-157, TB-500, GHRPs — no marketing authorization (nicht verkehrsfähige Arzneimittel). Cannot be legally sold for human use. Research chemicals face AMG restrictions on placing unauthorized medicines on the market.
Banned / Restricted
Medicines without marketing authorization (nicht verkehrsfähig). Doping-relevant peptides face additional Anti-Doping-Gesetz restrictions. Customs (Zoll) may seize unauthorized imports.
Key Legislation
- Arzneimittelgesetz (AMG)
- Apothekenbetriebsordnung (ApBetrO)
- Digitale-Versorgung-Gesetz (DVG)
Peptides in Germany: FAQ
Sources
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.
Peptide Laws in Other Countries
Get international legal updates
Stay informed when country-specific legal pages, routing guidance, and safety guidance change.
No spam. Unsubscribe anytime.